Picture of Foxo Technologies logo

FOXO Foxo Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m-43.73%
3m-60.21%
6m-47.55%
1yr-71.31%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-93.53%
50d MA-47.49%
200d MA-65.82%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-91.19%
Return on Equityn/a
Operating Margin-202.15%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Foxo Technologies EPS forecast chart

Profile Summary

FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.

Directors

    Last Annual
    December 31st, 2024
    Last Interim
    December 31st, 2024
    Incorporated
    April 27th, 2020
    Public Since
    December 11th, 2020
    No. of Shareholders
    62
    No. of Employees
    24
    Sector
    Software & IT Services
    Industry
    Technology
    Exchange
    us flag iconNYSE MKT
    Shares in Issue
    35,843,767

    FOXO Share Price Performance

    Upcoming Events for FOXO

    Foxo Technologies Inc Reverse Split For FOXO.A - Ratio 1-10

    Q1 2025 Foxo Technologies Inc Earnings Release

    Q2 2025 Foxo Technologies Inc Earnings Release

    Similar to FOXO

    FAQ